Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2003 September;55(3) > Minerva Urologica e Nefrologica 2003 September;55(3):157-72

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,984


eTOC

 

REVIEWS  


Minerva Urologica e Nefrologica 2003 September;55(3):157-72

Copyright © 2003 EDIZIONI MINERVA MEDICA

language: English

Antiviral drug-induced kidney and electrolytes disorders

Izzedine H., Launay-Vacher V., Isnard-Bagnis C., Deray G.

Department of Nephrology Pitie-Salpetriere Hospital, Paris, France


PDF  


HIV patients are at a high risk for nephrotoxicity (HIV-induced nephrotoxicity, HIVAN). As a result, renal insufficiency, tubular dysfunction and renal-related biological disorders are frequently observed in those patients. However, in some cases those defects or anomalies in renal function may be related to antiviral therapies rather than the disease itself. This article reviews the incidence, presentation, prevention and management of antiviral drug-induced renal dysfunction.

top of page

Publication History

Cite this article as

Corresponding author e-mail